You have access
Bevacizumab plus IFN-alpha-2a in First-line Treatment of Patients With Advanced or Metastatic Renal Cell Carcinoma: A Prospective German Non-interventional Study
WOLFGANG SCHULTZE-SEEMANN, HOLGER SCHULZ, BARBARA TSCHECHNE and MANUEL HÄCKL
Anticancer Research February 2019, 39 (2) 875-882; DOI: https://doi.org/10.21873/anticanres.13188
